Form 4 for CYTK CYTOKINETICS INC
Accepted 2026-03-18 00:00:00 ET · period of report 2026-03-17 · accession 0001061983-26-000027 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-03-18 | 2026-03-17 | CYTK | Malik Fady Ibraham | EVP Research, Development | S - Sale | $62.15 | -12.0K | 158.3K | -7% | -$747.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-17 | S | D | 4,397 | $62.15 | 153,902 | D | — | — | |
| 2 | Common | Common Stock | 2026-03-17 | S | D | 7,636 | $62.15 | 158,299 | D | — | — |